A Clinical Study to Investigate the Safety and Immunogenicity of rVSV∆G-SUDV-GP, a Sudan Virus (SUDV) Vaccine for the Prevention of SUDV Disease in Adults in Good General Health

计划入组 112 人 · 首次发布于 2026 年 5 月 4 日

Monovalent Chimpanzee Adenoviral-Vectored Sudan Ebolavirus Vaccine in Healthy Adults

计划入组 125 人 · 首次发布于 2023 年 9 月 14 日

Evaluation of Safety and Immunogenicity of rVSVΔG-SEBOV-GP Vaccine in Adults With Good General Health

计划入组 36 人 · 首次发布于 2023 年 2 月 13 日

GEO-EM03

Sudan Ebola Virus Vaccine (Soligenix)

rVSV Sudan ebola virus vaccine (Emergent BioSolutions)

Assembly Biosciences

United States

AbbVie CDR (CAD Hedged)

United States

Enanta Pharmaceuticals

United States

HHS Quietly Advances Marburg and Sudan Ebolavirus Vaccine Development Despite Kennedy's Vaccine Skepticism

Uganda Launches Groundbreaking First-Ever Ebola Sudan Vaccine Trial with WHO Support

Sabin Launches U.S. Phase 2 Trial for Marburg Vaccine Amid Rising Global Outbreaks